Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of
Continue reading »
Home ยป
FDA approves immunotherapy for dMMR endometrial cancer
The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced
Continue reading »
3-D holographic microscopy powered by deep-learning deciphers cancer immunotherapy
Live tracking and analyzing of the dynamics of chimeric antigen receptor (CAR) T-cells targeting cancer cells can open new avenues
Continue reading »
Bladder Cancer Indication Withdrawn for Durvalumab
After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Continue reading »
Immunotherapy: The Future of Lung Cancer Treatment?
Lung cancer is one of the most common types of cancer worldwide and accounts for around one fifth of cancer-related
Continue reading »
From scorpion to immunotherapy: Team repurposes nature’s toxin for CAR T
City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX),
Continue reading »
Cancer vaccine could boost the effectiveness of immunotherapy
Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able to boost the effectiveness of
Continue reading »
Study shows inhibition of gene helps overcome resistance to immunotherapy
Cancer immunology drugs, which harness the body’s immune system to better attack cancer cells, have significantly changed the face of
Continue reading »
Prostate cancer ‘super responders’ live for two years on immunotherapy
Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more
Continue reading »
Immunotherapy could work against bowel cancers resistant to important targeted treatment
Patients with bowel cancer who have stopped responding to a widely used targeted drug could benefit from immunotherapy, a major
Continue reading »